Cargando…

A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients

We analysed data from 80 patients who tested positive for SARS‐CoV‐2 RNA who had previously been HLA typed to support transplantation. Data were combined from two adjacent centres in Manchester and Leeds to achieve a sufficient number for early analysis. HLA frequencies observed were compared agains...

Descripción completa

Detalles Bibliográficos
Autores principales: Poulton, Kay, Wright, Paul, Hughes, Pamela, Savic, Sinisa, Welberry Smith, Matthew, Guiver, Malcolm, Morton, Muir, van Dellen, David, Tholouli, Eleni, Wynn, Robert, Clark, Brendan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361549/
https://www.ncbi.nlm.nih.gov/pubmed/32623831
http://dx.doi.org/10.1111/iji.12505
_version_ 1783559381462286336
author Poulton, Kay
Wright, Paul
Hughes, Pamela
Savic, Sinisa
Welberry Smith, Matthew
Guiver, Malcolm
Morton, Muir
van Dellen, David
Tholouli, Eleni
Wynn, Robert
Clark, Brendan
author_facet Poulton, Kay
Wright, Paul
Hughes, Pamela
Savic, Sinisa
Welberry Smith, Matthew
Guiver, Malcolm
Morton, Muir
van Dellen, David
Tholouli, Eleni
Wynn, Robert
Clark, Brendan
author_sort Poulton, Kay
collection PubMed
description We analysed data from 80 patients who tested positive for SARS‐CoV‐2 RNA who had previously been HLA typed to support transplantation. Data were combined from two adjacent centres in Manchester and Leeds to achieve a sufficient number for early analysis. HLA frequencies observed were compared against two control populations: first, against published frequencies in a UK deceased donor population (n = 10,000) representing the target population of the virus, and second, using a cohort of individuals from the combined transplant waiting lists of both centres (n = 308), representing a comparator group of unaffected individuals of the same demographic. We report a significant HLA association with HLA‐ DQB1*06 (53% vs. 36%; p < .012; OR 1.96; 95% CI 1.94–3.22) and infection. A bias towards an increased representation of HLA‐A*26, HLA‐DRB1*15, HLA‐DRB1*10 and DRB1*11 was also noted but these were either only significant using the UK donor controls, or did not remain significant after correction for multiple tests. Likewise, HLA‐A*02, HLA‐B*44 and HLA‐C*05 may exert a protective effect, but these associations did not remain significant after correction for multiple tests. This is relevant information for the clinical management of patients in the setting of the current SARS‐CoV‐2 pandemic and potentially in risk‐assessing staff interactions with infected patients.
format Online
Article
Text
id pubmed-7361549
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73615492020-07-15 A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients Poulton, Kay Wright, Paul Hughes, Pamela Savic, Sinisa Welberry Smith, Matthew Guiver, Malcolm Morton, Muir van Dellen, David Tholouli, Eleni Wynn, Robert Clark, Brendan Int J Immunogenet Hla & Disease We analysed data from 80 patients who tested positive for SARS‐CoV‐2 RNA who had previously been HLA typed to support transplantation. Data were combined from two adjacent centres in Manchester and Leeds to achieve a sufficient number for early analysis. HLA frequencies observed were compared against two control populations: first, against published frequencies in a UK deceased donor population (n = 10,000) representing the target population of the virus, and second, using a cohort of individuals from the combined transplant waiting lists of both centres (n = 308), representing a comparator group of unaffected individuals of the same demographic. We report a significant HLA association with HLA‐ DQB1*06 (53% vs. 36%; p < .012; OR 1.96; 95% CI 1.94–3.22) and infection. A bias towards an increased representation of HLA‐A*26, HLA‐DRB1*15, HLA‐DRB1*10 and DRB1*11 was also noted but these were either only significant using the UK donor controls, or did not remain significant after correction for multiple tests. Likewise, HLA‐A*02, HLA‐B*44 and HLA‐C*05 may exert a protective effect, but these associations did not remain significant after correction for multiple tests. This is relevant information for the clinical management of patients in the setting of the current SARS‐CoV‐2 pandemic and potentially in risk‐assessing staff interactions with infected patients. John Wiley and Sons Inc. 2020-07-05 2020-08 /pmc/articles/PMC7361549/ /pubmed/32623831 http://dx.doi.org/10.1111/iji.12505 Text en © 2020 The Authors. International Journal of Immunogenetics published by John Wiley & Sons Ltd https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Hla & Disease
Poulton, Kay
Wright, Paul
Hughes, Pamela
Savic, Sinisa
Welberry Smith, Matthew
Guiver, Malcolm
Morton, Muir
van Dellen, David
Tholouli, Eleni
Wynn, Robert
Clark, Brendan
A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients
title A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients
title_full A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients
title_fullStr A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients
title_full_unstemmed A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients
title_short A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients
title_sort role for human leucocyte antigens in the susceptibility to sars‐cov‐2 infection observed in transplant patients
topic Hla & Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361549/
https://www.ncbi.nlm.nih.gov/pubmed/32623831
http://dx.doi.org/10.1111/iji.12505
work_keys_str_mv AT poultonkay aroleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT wrightpaul aroleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT hughespamela aroleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT savicsinisa aroleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT welberrysmithmatthew aroleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT guivermalcolm aroleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT mortonmuir aroleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT vandellendavid aroleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT tholoulieleni aroleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT wynnrobert aroleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT clarkbrendan aroleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT poultonkay roleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT wrightpaul roleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT hughespamela roleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT savicsinisa roleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT welberrysmithmatthew roleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT guivermalcolm roleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT mortonmuir roleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT vandellendavid roleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT tholoulieleni roleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT wynnrobert roleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients
AT clarkbrendan roleforhumanleucocyteantigensinthesusceptibilitytosarscov2infectionobservedintransplantpatients